Protagonist Therapeutics (PTGX) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Protagonist Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
May 7, 2020 4:31 PM EDTNEWARK, Calif., May 7, 2020 /PRNewswire/ --Â Protagonist Therapeutics, Inc. (Nasdaq: PTGX) today reported its financial results for the first quarter ended March 31, 2020, and provided an update on clinical development programs.
